HB1114 amends Hawaii's sterile needle and syringe exchange program to enhance safety and effectiveness.
HB1114 updates Hawaii's sterile needle and syringe exchange program to align with current recommendations from the Centers for Disease Control and Prevention and the White House Office of National Drug Control Policy. The bill transitions the program from a one-to-one exchange model to a needs-based distribution system, allowing participants to receive sufficient sterile needles and syringes to reduce the risk of infection.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.